Liyam Chitayat
Liyam Chitayat is a PhD candidate and Hertz fellow at MIT. She completed her MSc in biomedical engineering before helping establish Israel’s DARPA-BTO equivalent, where she served as program manager across synthetic and computational biology to build national biodefense capabilities and evaluate emerging acceleratory technologies. Liyam co-founded Nucleate Israel and served as EVP of global strategy for Nucleate HQ. She is a fellow at the Johns Hopkins Bloomberg School of Public Health and a Council on Strategic Risks (CSR) fellow. Her research focuses on integration between natural and synthetic life, mitochondrial engineering, and interfaces for human health and performance.